A deescalation strategy involving switching from ticagrelor to clopidogrel in patients with acute myocardial infarction (AMI) ...

Increased risk seen for adverse cardiovascular events, including myocardial infarction, stroke, heart failure, mortality ...

A new study that looked at possible improvements in post-acute care quality and outcomes following the 2014 Improving ...

Clinicians should be asking patients about cannabis use, particularly if there are cardiovascular concerns, say researchers.

In-hospital mortality in patients with AMI can be predicted with a risk-standardized model that includes patient factors, such as age and cardiogenic shock.

Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.

A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...

Among stroke survivors, the risk of developing dementia after stroke is significantly high, highlighting the need for targeted prevention strategies.

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

Overall, though, the meta-analysis identified a reduction in ischemia—but not in hard outcomes—with early treatment.